Physician
Lopez, Marco
Lopez, Marco was paid $6.58M by Medicaid between Jan 2018 and Dec 2024, across 74 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 25% of everything it billed.
33Billing provider infoLOPEZ, MARCO
PHARR, TX 78577
PHARR, TX 78577
33aNPI1073892071assigned 08/08/2011
33bProvider typePediatrics Physician
28Total paid$6.58M
24GClaims252,336
24DCodes billed74
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#54 of 1,136
Median peer was paid$329K
This provider vs. median20×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 340 | $11K | |
| 2019 | 673 | $21K | |
| 2020 | 8,008 | $174K | |
| 2021 | 52,902 | $1.21M | |
| 2022 | 77,126 | $2.02M | |
| 2023 | 64,167 | $1.61M | |
| 2024incomplete | 49,120 | $1.54M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 25% | 47,141 | 36,411 | $1.65M |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 14% | 25,788 | 20,344 | $920K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 8.8% | 8,477 | 7,418 | $582K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.1% | 10,865 | 9,690 | $535K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.8% | 5,566 | 5,408 | $445K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.5% | 5,834 | 5,485 | $429K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 6.1% | 9,000 | 7,670 | $404K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.8% | 3,304 | 3,075 | $253K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.8% | 25,228 | 9,858 | $252K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.6% | 3,341 | 3,099 | $234K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.1% | 15,662 | 14,101 | $206K |
| 99429 | 1.5% | 3,119 | 2,996 | $100K |
62 more codes
| 99203 | Doctor's office visit, new patient (routine) | 1.4% | 1,680 | $91K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 14,052 | $85K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 4,437 | $73K |
| 92552 | <1% | 3,226 | $37K | |
| 90461 | <1% | 13,484 | $35K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,002 | $32K |
| 99051 | <1% | 6,498 | $22K | |
| 87807 | <1% | 1,956 | $20K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,903 | $20K |
| 92551 | <1% | 3,721 | $17K | |
| 92567 | <1% | 1,354 | $17K | |
| 99381 | <1% | 218 | $17K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 789 | $16K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,895 | $14K |
| 0071A | <1% | 304 | $12K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 358 | $12K |
| 0072A | <1% | 253 | $10K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 80 | $6K |
| 86328 | <1% | 90 | $6K | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 524 | $5K |
| 99383 | <1% | 44 | $3K | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 1,413 | $3K |
| 97169 | <1% | 107 | $3K | |
| 90473 | <1% | 712 | $2K | |
| 0081A | <1% | 40 | $1K | |
| 90686 | <1% | 2,711 | $963.53 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 104 | $838.75 |
| 99050 | <1% | 56 | $836.64 | |
| 90677 | <1% | 811 | $762.61 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,159 | $749.26 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 31 | $729.94 |
| 0073A | <1% | 12 | $480.00 | |
| 0082A | <1% | 13 | $440.00 | |
| 0004A | <1% | 14 | $320.00 | |
| 81003 | <1% | 126 | $213.57 | |
| 86580 | <1% | 28 | $151.12 | |
| 83655 | <1% | 14 | $142.38 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 105 | $42.25 |
| 99001 | <1% | 40 | $5.40 | |
| 90651 | <1% | 975 | $0.50 | |
| 90620 | <1% | 366 | $0.19 | |
| 90723 | 0% | 2,292 | $0.00 | |
| 96127 | 0% | 110 | $0.00 | |
| 90680 | 0% | 394 | $0.00 | |
| 90696 | 0% | 735 | $0.00 | |
| 90716 | 0% | 349 | $0.00 | |
| 91307 | 0% | 672 | $0.00 | |
| 90647 | 0% | 1,192 | $0.00 | |
| 90656 | 0% | 119 | $0.00 | |
| 90633 | 0% | 1,771 | $0.00 | |
| 90715 | 0% | 487 | $0.00 | |
| 90707 | 0% | 349 | $0.00 | |
| 90648 | 0% | 1,829 | $0.00 | |
| 90670 | 0% | 2,305 | $0.00 | |
| 90734 | 0% | 1,059 | $0.00 | |
| 90681 | 0% | 1,160 | $0.00 | |
| 90658 | 0% | 670 | $0.00 | |
| 90700 | 0% | 792 | $0.00 | |
| 99173 | 0% | 1,590 | $0.00 | |
| 90710 | 0% | 1,310 | $0.00 | |
| 91308 | 0% | 76 | $0.00 | |
| 91300 | 0% | 45 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.